您的浏览器禁用了JavaScript(一种计算机语言,用以实现您与网页的交互),请解除该禁用,或者联系我们。 [欧洲疾病预防控制中心]:2024年综合呼吸道病毒监测报告协议1.7版 - 发现报告

2024年综合呼吸道病毒监测报告协议1.7版

报告封面

Reporting Protocol for integrated respiratoryvirus surveillance, version 1.7 Contents Contents ................................................................................................................... 2 How to use this document................................................................................................ 5Finding further information .............................................................................................. 5Copyright ........................................................................................................................ 5 Aim................................................................................................................................. 6Objectives ....................................................................................................................... 6Record types ................................................................................................................... 6Case definitions ............................................................................................................... 7 Reporting to TESSy .................................................................................................... 9 When, what and how to report......................................................................................... 9Preparing data................................................................................................................. 9Checking metadata .......................................................................................................... 9Submitting your data ....................................................................................................... 9Finalising your submission.............................................................................................. 10Navigating EpiPulse cases platform ................................................................................. 10TESSy/EpiPulse Cases Help Desk .................................................................................... 10 Annex ..................................................................................................................... 11 Revisions of metadata sets............................................................................................. 11Current record type versions .......................................................................................... 11RESPIAGGR metadata.................................................................................................... 12RESPISEVERE metadata................................................................................................. 17RESPISURV metadata .................................................................................................... 22SARISURV metadata ...................................................................................................... 36SARISURVDENOM metadata........................................................................................... 52INFLSARIAGGR metadata............................................................................................... 58INFLCLINAGGR metadata............................................................................................... 75INFLANTIVIR metadata.................................................................................................. 83NCOVVARIANT metadata ............................................................................................... 94 The following changes have been made to SARISURV: •08/03/2024: BrandLastCOVID19Dose coded value list has been updated.•07/12/2023: BrandLastCOVID19Dose coded value list has been updated.•27/11/2023: BA.2.86 added to the coded value list for VirusVariantCOVID•Precondition (repeatable variable with coded value list) and Complications (repeatablevariable with coded value list) have been added. The individual variables for preconditionsand complications have been removed: ASTH, CANC, CARDIACDIS, DIAB, HYPERT, HIV,IMMUNEOTH, IMMUNO, KIDNEY, LIVER, LUNG, DEMENT, OBES, PREG, PREGTRIM, SMOKE,ARDS, BRONCH, COAG, ENCEPH, LONGCOVID, MYOCARD, PIMS, PNEU. Precondition Codedvalue list for Precondition now includes DOWNS (Down's Syndrome) and PREM (Prematurity).•Variable OtherSymptoms changed to be repeatable, with coded value list added. Theindividual variables for symptoms other than cough and fever have been removed: ANOS,AGEUS, DIARR, HEAD, PAINMUSC, RUNOS, SBREATH, SORETHR, VOMIT, GENERALDETER.•ResultSARSCoV2 was added which replaces the two previous variables ResultPCRSARSCoV2and ResultRADTSARSCoV2 (which have been removed). Additionally,ResultCtValuePCRSARSCoV2, PreviousInfluenza, and WgsEnaId have been removed.•RSVtype variable added.•RSV vaccination variables added (RSVvaccinated, RSVvaccinatedMother, RSVvacDate,RSVVacProduct).•NumberOfCovid19VaccDose, BrandLastCOVID19Dose, DateLastCOVID19VaccDose have beenadded. The f